Allergic gastrointestinal motility disorders in infancy and early childhood

Ralf G Heine1

  • 1Department of Gastroenterology & Clinical Nutrition Royal Children's Hospital, University of Melbourne, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. ralf.heine@rch.org.au

Insights

Food protein allergy can cause gastrointestinal issues like reflux, constipation, and colic in infants. Diagnosis involves considering allergy and may require biopsies, with treatment focusing on hypoallergenic diets.

Area of Science:

  • Pediatric Gastroenterology
  • Allergology
  • Clinical Nutrition

Background:

  • Infantile functional gastrointestinal disorders (FGIDs) such as gastro-oesophageal reflux, constipation, and colic are highly prevalent.
  • Dietary elimination of specific food proteins can improve symptoms in a subset of infants with these FGIDs.
  • Food protein-induced gastrointestinal motility disorders warrant consideration in the differential diagnosis of persistent infant FGIDs unresponsive to conventional therapies.

Observation:

  • Clinical presentation of food protein-induced gastrointestinal motility disorders lacks specific features and reliable laboratory markers.
  • Gastrointestinal biopsies prior to dietary intervention may offer crucial diagnostic insights.
  • Early identification is vital to prevent adverse nutritional outcomes and feeding difficulties.

Findings:

  • Diagnosis of food protein-induced gastrointestinal motility disorders is challenging due to non-specific symptoms and lack of biomarkers.
  • Gastrointestinal biopsies can be informative for diagnosis.
  • Hypoallergenic formulas and maternal elimination diets (for breastfed infants) are primary treatment strategies.

Implications:

  • Consider gastrointestinal food allergy in infants with persistent FGIDs unresponsive to standard treatments.
  • Gastrointestinal biopsies may aid in diagnosing these motility disorders.
  • Prompt diagnosis and management are crucial for preventing long-term feeding issues and nutritional deficits in affected infants.

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...